<div class="article">
	<h3>Business Brief -- Abbott Laboratories:
   Net Rose 14% on Increase
   In Sales in First Quarter</h3>
	<div class="article-info">
		<ul>
			<li>Author: null</li>
			<li>Date: 04/10/90</li>
		</ul>
	</div>
	<p class="article-leader">Abbott Laboratories reported a 14% rise in net income for
the first quarter on an 11% sales rise, continuing the recent
solid growth by the North Chicago, Ill., maker of hospital
products and pharmaceuticals.
   Net income was $225 million, or $1.02 a share, up from the
year-earlier period's $198 million, or 88 cents a share.
Sales rose to $1.44 billion from $1.3 billion.</p>
	<div class="article-body"><p>Abbott said the introduction of products with higher
profit margins, as well as productivity increases contributed
to the upturn.</p>
<p>The company's international sales increased more than
domestic sales, climbing about 12% compared with 10% growth
in the U.S.</p>
<p>In New York Stock Exchange composite trading yesterday,
Abbott rose 50 cents to $68.125.</p>
<p></p></div>
</div>
